SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-007935
Filing Date
2024-01-30
Accepted
2024-01-30 06:05:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm244401-1_424b5.htm 424B5 766107
2 GRAPHIC lg_seelostherapeutics-4clr.jpg GRAPHIC 13585
  Complete submission text file 0001104659-24-007935.txt   786204
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276119 | Film No.: 24575728
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)